United Therapeutics Corporation (UTHR) Insider Trading
- $999,400.80
- $773,721,457.77
- Nov. 11, 2024
- Martine A Rothblatt
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| April 17, 2023 | CEO | 8,000 | $230.47 | Sell | $1,843,760.00 | |
| April 13, 2023 | CEO | 8,000 | $230.69 | Sell | $1,845,520.00 | |
| April 11, 2023 | CEO | 8,000 | $225.57 | Sell | $1,804,560.00 | |
| April 6, 2023 | EVP | 6,000 | $232.79 | Sell | $1,396,740.00 | |
| April 6, 2023 | CEO | 8,000 | $229.12 | Sell | $1,832,960.00 | |
| April 4, 2023 | CEO | 8,000 | $226.26 | Sell | $1,810,080.00 | |
| March 30, 2023 | CEO | 8,000 | $217.14 | Sell | $1,737,120.00 | |
| March 27, 2023 | CEO | 8,000 | $217.04 | Sell | $1,736,320.00 | |
| March 24, 2023 | CEO | 8,000 | $217.95 | Sell | $1,743,600.00 | |
| March 22, 2023 | CEO | 8,000 | $216.01 | Sell | $1,728,080.00 | |
| March 20, 2023 | CEO | 8,000 | $223.96 | Sell | $1,791,680.00 | |
| March 17, 2023 | CEO | 8,000 | $217.91 | Sell | $1,743,280.00 | |
| March 16, 2023 | EVP | 6,000 | $214.39 | Sell | $1,286,340.00 | |
| March 9, 2023 | CEO | 8,000 | $222.63 | Sell | $1,781,040.00 | |
| March 7, 2023 | CEO | 8,000 | $239.16 | Sell | $1,913,280.00 | |
| March 2, 2023 | CEO | 8,000 | $244.50 | Sell | $1,956,000.00 | |
| Feb. 27, 2023 | CEO | 8,000 | $249.14 | Sell | $1,993,120.00 | |
| Feb. 24, 2023 | CEO | 8,000 | $249.27 | Sell | $1,994,160.00 | |
| Feb. 22, 2023 | CEO | 8,000 | $246.77 | Sell | $1,974,160.00 | |
| Feb. 13, 2023 | CEO | 8,000 | $254.76 | Sell | $2,038,080.00 | |
| Feb. 8, 2023 | CEO | 8,000 | $253.38 | Sell | $2,027,040.00 | |
| Feb. 2, 2023 | EVP | 6,000 | $254.63 | Sell | $1,527,780.00 | |
| Feb. 1, 2023 | Director | 700 | $261.33 | Sell | $182,931.00 | |
| Jan. 31, 2023 | CEO | 8,000 | $261.50 | Sell | $2,092,000.00 | |
| Jan. 27, 2023 | CEO | 8,000 | $260.01 | Sell | $2,080,080.00 | |
| Jan. 25, 2023 | CEO | 8,000 | $264.21 | Sell | $2,113,680.00 | |
| Jan. 23, 2023 | CEO | 8,000 | $258.97 | Sell | $2,071,760.00 | |
| Jan. 19, 2023 | EVP | 6,000 | $258.95 | Sell | $1,553,700.00 | |
| Jan. 19, 2023 | CEO | 8,000 | $259.60 | Sell | $2,076,800.00 | |
| Jan. 17, 2023 | CEO | 8,000 | $260.50 | Sell | $2,084,000.00 | |
| Jan. 13, 2023 | CEO | 8,000 | $261.52 | Sell | $2,092,160.00 | |
| Jan. 11, 2023 | CEO | 8,000 | $261.39 | Sell | $2,091,120.00 | |
| Jan. 9, 2023 | CEO | 8,000 | $267.86 | Sell | $2,142,880.00 | |
| Jan. 6, 2023 | CEO | 8,000 | $276.29 | Sell | $2,210,320.00 | |
| Jan. 3, 2023 | Director | 700 | $276.26 | Sell | $193,382.00 | |
| Dec. 27, 2022 | CEO | 8,000 | $274.34 | Sell | $2,194,720.00 | |
| Dec. 23, 2022 | CEO | 8,000 | $277.61 | Sell | $2,220,880.00 | |
| Dec. 20, 2022 | CEO | 8,000 | $272.20 | Sell | $2,177,600.00 | |
| Dec. 15, 2022 | EVP | 12,000 | $196.31 | Sell | $2,355,720.00 | |
| Dec. 14, 2022 | CEO | 6,310 | $276.75 | Sell | $1,746,292.50 | |
| Dec. 12, 2022 | CEO | 8,000 | $279.27 | Sell | $2,234,160.00 | |
| Dec. 9, 2022 | Director | 1,010 | $282.00 | Sell | $284,820.00 | |
| Dec. 8, 2022 | CEO | 8,000 | $278.65 | Sell | $2,229,200.00 | |
| Dec. 6, 2022 | CEO | 8,000 | $274.29 | Sell | $2,194,320.00 | |
| Dec. 1, 2022 | Director | 700 | $279.89 | Sell | $195,923.00 | |
| Dec. 1, 2022 | EVP | 6,000 | $277.65 | Sell | $1,665,900.00 | |
| Nov. 30, 2022 | CEO | 8,000 | $277.53 | Sell | $2,220,240.00 | |
| Nov. 28, 2022 | CEO | 8,000 | $270.07 | Sell | $2,160,560.00 | |
| Nov. 25, 2022 | CEO | 8,000 | $267.26 | Sell | $2,138,080.00 | |
| Nov. 23, 2022 | CEO | 8,000 | $268.56 | Sell | $2,148,480.00 |
Insiders are both buying and selling United Therapeutics Corporation stock.
The insider traders at United Therapeutics Corporation are: Martine A Rothblatt, Paul A Mahon, Roger Jeffs, Martine A. Rothblatt, Martine Rothblatt, Christopher Causey, John Maxim Ferrari, Raymond Dwek, Christopher Patusky, Paul Mahon, David Zaccardelli, Richard Giltner, James Edgemond, Nilda Mesa, Louis W Sullivan, Tommy G Thompson, Judy D Olian, Michael Benkowitz, Ray Kurzweil, Paul A. Mahon, Louis Sullivan, R Paul Gray, Judy D. Olian, Tommy G. Thompson, DWEK RAYMOND, and MAHON PAUL A
The most active insider trader at United Therapeutics Corporation is Martine A Rothblatt with 386 trades.
Martine A Rothblatt has sold the most United Therapeutics Corporation stock with a total value of $372,318,923.20.
Martine A Rothblatt has bought the most United Therapeutics Corporation stock with a total value of $1,217,751.60.
The most recent insider trade for United Therapeutics Corporation was on Nov. 11, 2024.
The single biggest insider buy for United Therapeutics Corporation was from Martine A Rothblatt with a total value of $466,650.00 on Dec. 21, 2012.
The single biggest insider sell for United Therapeutics Corporation was from Michael Benkowitz with a total value of $8,084,500.00 on Aug. 7, 2024.